The association of chronic kidney disease-mineral bone disorder and cardiovascular risk

Area of Science:

• Nephrology
• Cardiology
• Endocrinology

Background:

• Chronic kidney disease-mineral bone disorder (CKD-MBD) is a complex condition affecting mineral metabolism in renal disease.
• Previously termed 'renal osteodystrophy' or 'renal bone disease', CKD-MBD is now understood as a systemic issue.
• CKD-MBD is increasingly recognized for its significant impact on patient health outcomes.

Purpose of the Study:

• To review the evidence linking CKD-MBD to cardiovascular morbidity and mortality.
• To explore the underlying mechanisms connecting CKD-MBD and cardiovascular complications.
• To summarize the effects of CKD-MBD treatments on cardiovascular outcomes in renal patients.

Main Methods:

• Literature review of existing studies on CKD-MBD.
• Analysis of data correlating CKD-MBD markers with cardiovascular events.
• Examination of proposed pathophysiological pathways.

Main Results:

• Evidence suggests a strong association between CKD-MBD and increased cardiovascular morbidity and mortality.
• Specific mechanisms linking mineral dysregulation to cardiovascular damage are being elucidated.
• Current treatments for CKD-MBD may contribute to cardiovascular risks.

Conclusions:

• CKD-MBD is a critical factor in the elevated cardiovascular risk observed in chronic kidney disease patients.
• Understanding the mechanisms and treatment impacts is crucial for managing cardiovascular health in CKD.
• Further research is needed to optimize CKD-MBD management for cardiovascular benefit.